Help wanted: low provider density is associated with advanced stage cervical cancer

C Calo, DA Barrington, EM Mclaughlin… - International Journal of …, 2022 - ijgc.bmj.com
Background Patients in rural areas have a higher incidence of cervical cancer with
increased rates of metastatic disease than their urban counterparts. Objective To evaluate …
Save Cite Cited by 1 Related articles All 7 versions

Universal germline screening for Lynch syndrome in endometrial cancer

DA Barrington, CM Cosgrove… - Gynecologic …, 2020 - gynecologiconcology-online.net
Objective: Universal Lynch syndrome (LS) screening in endometrial cancer (EC) has been
recommended. We sought to explore different testing strategies as part of a statewide LS …
Save Cite Cited by 1 Related articles All 2 versions

Racial disparities in hereditary gynecologic cancer risk assessment: What and why?

DA Barrington, S Batra, G McGwin… - Gynecologic …, 2018 - gynecologiconcology-online.net
Objective: The aim of this study was to compare referral patterns, genetic testing, and
pathogenic variant rates between black and white patients in a large southeastern …
Save Cite Related articles All 2 versions

Pembrolizumab in advanced recurrent endometrial cancer: A cost-effectiveness analysis

DA Barrington, SE Dilley… - Gynecologic …, 2018 - gynecologiconcology-online.net
Objective: To determine the cost-effectiveness of pembrolizumab, a PD-L1 antibody, in
recurrent endometrial cancer that has failed first-line chemotherapy in women with (MSI-H) …
Save Cite Related articles All 2 versions

High-high intermediate risk endometrial adenocarcinoma: A subset of early stage endometrial cancer patients who benefit from adjuvant therapy

BM Roane, MZ Kamal, T Rushton… - Gynecologic …, 2019 - gynecologiconcology-online.net
Objective: There is a group of early-stage endometrial cancer patients classified as high
intermediate risk (HIR) because of their increased risk of recurrence and lower OS. The use …
Save Cite Related articles All 2 versions